Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Oct;64(4):741-4.
doi: 10.1038/bjc.1991.390.

Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue

R Dittadi  1 , M Gion, V Pagan, A Brazzale, O Del Maschio, A Bargossi, A Busetto, G Bruscagnin
Affiliations
Free PMC article

Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue

R Dittadi et al. Br J Cancer. 1991 Oct.
Free PMC article

Abstract

Epidermal growth factor receptors (EGFr) were measured using a radioligand binding assay, in membrane preparations from 51 human non-small cell lung cancers and in normal tissue of the same patients. The binding characteristics of EGFr were similar in tumour and normal lung membranes (range of dissociation constant of high affinity sites: 0.1-0.6 nM). However, the concentrations in tumours (median, 16.4 fmol mg-1 of protein; range, 1.5-176) were significantly higher than in normal tissues (median, 7.4 fmol mg-1 of protein; range, 1.9-13.4). The receptor levels in normal tissue were normally distributed. It was therefore possible to define a normal/pathologic cut-off level (12.9 fmol mg-1 of protein). In 57% of cases EGFr in cancer was higher than the cut-off. No relationships were found between receptor concentrations and positivity rates of EGFr and histology, stage, lymph node positivity and pT. A trend for a direct relation between receptor positivity and grading was found.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Br J Cancer. 1989 Apr;59(4):559-62 - PubMed
    1. Br J Cancer. 1986 Aug;54(2):265-9 - PubMed
    1. Cancer Res. 1989 Mar 1;49(5):1313-7 - PubMed
    1. Lancet. 1987 Jun 20;1(8547):1398-402 - PubMed
    1. Br J Cancer. 1987 May;55(5):513-6 - PubMed

Publication types

-